IL-6 deregulation in tumor cells reprograms the STAT3 pathway in metastatic cells and promotes the recruitment of myeloid suppressor cells and macrophage polarization toward a phenotype that allows tumor cells to escape immune system surveillance [94]. The gene discussed is STAT3; the disease is neoplasm.